• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 11,944 shares, decreasing direct ownership by 11% to 96,466 units (SEC Form 4)

    6/3/26 5:00:10 PM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email
    SEC FORM 4SEC Form 4
    FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0287
    Estimated average burden
    hours per response:0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Moore Mary Ann E

    (Last)(First)(Middle)
    1301 CONCORD TERRACE

    (Street)
    SUNRISE FLORIDA 33323

    (City)(State)(Zip)

    UNITED STATES

    (Country)
    2. Issuer Name and Ticker or Trading Symbol
    Pediatrix Medical Group, Inc. [ MD ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    EVP, GC, Chief Admin Off & Sec
    2a. Foreign Trading Symbol
    3. Date of Earliest Transaction (Month/Day/Year)
    06/01/2026
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    4. If Amendment, Date of Original Filed (Month/Day/Year)

    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeVAmount(A) or (D)Price
    Common Stock06/01/2026F(1)11,944D$21.5496,466D
    Common Stock93,424IBy Trust(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    1. Represents 11,944 restricted shares withheld for payment of taxes upon vesting of shares.
    2. The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
    /s/ Mary Ann E. Moore06/03/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 4: SEC 1474 (03-26)
    Get the next $MD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO and Treasurer Rossi Kasandra H was granted 31,800 shares and covered exercise/tax liability with 3,701 shares, increasing direct ownership by 38% to 101,399 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    6/3/26 5:00:21 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Chief Executive Officer Ordan Mark S was granted 224,372 shares, covered exercise/tax liability with 19,119 shares and returned 97,174 shares to the company, increasing direct ownership by 36% to 410,884 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    6/3/26 5:00:13 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    EVP, Chief Invest & Strategy Neeb Don Gregory covered exercise/tax liability with 8,003 shares and was granted 63,888 shares, increasing direct ownership by 69% to 137,231 units (SEC Form 4)

    4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

    6/3/26 5:00:11 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $MD
    SEC Filings

    View All

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology

    Research Was Conducted Utilizing the Proprietary Pediatrix Clinical Data Warehouse Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced the publication of new research on probiotic use and necrotizing enterocolitis (NEC) in preterm infants, addressing pressing questions about one of the most controversial issues in the field of neonatology. The research was conducted by clinicians affiliated with the Pediatrix Center for Research, Education, Quality and Safety in collaboration with the NEC Society, utilizing data from the Pediatrix Clinical Data Warehouse (CDW), one of the largest databases of neonatal outcomes in the world. Data from the Ped

    6/3/26 4:30:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports First Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended March 31, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2026 first quarter, Pediatrix reported the following results: Net revenue of $476 million; Net income of $30 million; and Adjusted EBITDA of $58 million. "Our first quarter operating results exceeded our expectations, driven by top-line growth," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Our priorities for 2026 remain focused on maximizing quality driven support for our hospital partners. With robust cash flow a

    5/5/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr

    4/20/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form S-8 filed by Pediatrix Medical Group Inc.

    S-8 - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    5/21/26 4:35:26 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    5/7/26 4:30:17 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form 10-Q filed by Pediatrix Medical Group Inc.

    10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

    5/5/26 7:00:40 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Macquarie initiated coverage on Pediatrix Medical Group

    Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

    12/16/24 7:46:05 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Jefferies with a new price target

    Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

    9/26/24 7:37:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

    6/7/24 8:14:20 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    View All

    Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its board of directors has appointed Kurt D. Newman, M.D., former President and Chief Executive Officer of Children's National Hospital in Washington, D.C. and Professor Emeritus of Surgery and Pediatrics at George Washington University School of Medicine and Health Sciences, as an independent director, effective July 1, 2025. Dr. Newman, a surgeon and nationally recognized leader in pediatric healthcare and a long-term healthcare executive, served as President and Chief Executive Officer of Children's National Hospital for 12 years, after spending over 25 years there as a pediatric sur

    7/1/25 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

    Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

    1/13/25 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Board Appoints Sylvia Young as Independent Director

    Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

    5/4/23 4:05:00 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Financials

    Live finance-specific insights

    View All

    Pediatrix Medical Group Reports First Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended March 31, 2026. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.44. For the 2026 first quarter, Pediatrix reported the following results: Net revenue of $476 million; Net income of $30 million; and Adjusted EBITDA of $58 million. "Our first quarter operating results exceeded our expectations, driven by top-line growth," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Our priorities for 2026 remain focused on maximizing quality driven support for our hospital partners. With robust cash flow a

    5/5/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

    Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr

    4/20/26 6:45:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Pediatrix Medical Group Reports Fourth Quarter Results

    Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.50. For the 2025 fourth quarter, Pediatrix reported the following results: Net revenue of $494 million; Net income of $34 million; and Adjusted EBITDA of $66 million. "Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Ou

    2/19/26 6:00:00 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pediatrix Medical Group Inc.

    SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    11/13/24 4:30:24 PM ET
    $MD
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    10/31/24 11:54:57 AM ET
    $MD
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

    SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

    6/10/24 12:43:02 PM ET
    $MD
    Hospital/Nursing Management
    Health Care